MA39085A1 - Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne - Google Patents
Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienneInfo
- Publication number
- MA39085A1 MA39085A1 MA39085A MA39085A MA39085A1 MA 39085 A1 MA39085 A1 MA 39085A1 MA 39085 A MA39085 A MA 39085A MA 39085 A MA39085 A MA 39085A MA 39085 A1 MA39085 A1 MA 39085A1
- Authority
- MA
- Morocco
- Prior art keywords
- combination
- cineol
- amoxicillin
- treatment
- bacterial infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne une combinaison de cinéol et d' amoxicilline pour une utilisation dans le traitement d'une infection bactérienne chez un sujet. La présente combinaison peut en outre comprendre un inhibiteur de p-lactamases, de préférence de l'acide clavulanique. La combinaison selon l'invention permet en particulier de lutter contre les infections causées par des bactéries résistantes aux antibiotiques, de préférence aux antibiotiques de la famille des p-lactamines.
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MA39085A MA39085B1 (fr) | 2016-06-02 | 2016-06-02 | Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne |
BR112018074913-3A BR112018074913B1 (pt) | 2016-06-02 | 2017-06-02 | Formulação farmacêutica de cineol e amoxicilina |
CN201780041549.7A CN109562182A (zh) | 2016-06-02 | 2017-06-02 | 包含桉树脑和阿莫西林的药物制剂 |
PCT/MA2017/000014 WO2017209588A2 (fr) | 2016-06-02 | 2017-06-02 | Formulation pharmaceutique de cinéol et d'amoxicilline |
CA3026323A CA3026323A1 (fr) | 2016-06-02 | 2017-06-02 | Formulation pharmaceutique de cineol et d'amoxicilline |
EP17743405.7A EP3463479A2 (fr) | 2016-06-02 | 2017-06-02 | Formulation pharmaceutique de cinéol et d'amoxicilline |
JP2019515760A JP7033586B2 (ja) | 2016-06-02 | 2017-06-02 | シネオールとアモキシシリンとを含む医薬製剤 |
EA201892808A EA201892808A1 (ru) | 2016-06-02 | 2017-06-02 | Фармацевтический препарат, включающий цинеол и амоксициллин |
MA044286A MA44286A (fr) | 2016-06-02 | 2017-06-02 | Formulation pharmaceutique de cinéol et d'amoxicilline |
US16/306,262 US11872216B2 (en) | 2016-06-02 | 2017-06-02 | Pharmaceutical formulation comprising cineole and amoxicillin |
US18/408,636 US20240148702A1 (en) | 2016-06-02 | 2024-01-10 | Pharmaceutical formulation comprising cineole and amoxicillin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MA39085A MA39085B1 (fr) | 2016-06-02 | 2016-06-02 | Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne |
Publications (2)
Publication Number | Publication Date |
---|---|
MA39085A1 true MA39085A1 (fr) | 2017-12-29 |
MA39085B1 MA39085B1 (fr) | 2018-06-29 |
Family
ID=61167677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39085A MA39085B1 (fr) | 2016-06-02 | 2016-06-02 | Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA201892808A1 (fr) |
MA (1) | MA39085B1 (fr) |
-
2016
- 2016-06-02 MA MA39085A patent/MA39085B1/fr unknown
-
2017
- 2017-06-02 EA EA201892808A patent/EA201892808A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EA201892808A1 (ru) | 2019-05-31 |
MA39085B1 (fr) | 2018-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201991523A1 (ru) | Комбинированная терапия амидин-замещенными бета-лактамными соединениями и ингибиторами бета-лактамазы при инфекциях, вызванных бактериальными штаммами, резистентными к антибиотикам | |
MX362683B (es) | Composiciones farmacéuticas que comprenden antibiótico de beta-lactama, sulbactama e inhibidor de beta-lactamasa. | |
MA37383A1 (fr) | Compose heterobicycliques comme inhibiteurs de la beta lactamase | |
PH12019500558A1 (en) | Beta-lactamase inhibitor compounds | |
MA32025B1 (fr) | Inhibiteurs des beta-lactamases | |
BR112013032711A2 (pt) | composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase | |
BR112017010132A2 (pt) | terapia combinada para tratamento de infecções bacterianas resistentes | |
FR3029790B1 (fr) | Microbille d'hydrogel de chitosane | |
WO2018151861A8 (fr) | Procédés de traitement de la schizophrénie | |
RU2015102562A (ru) | Фармацевтические композиции и способ лечения маститов | |
WO2015046505A8 (fr) | Anticorps anti-lps o11 | |
WO2021022163A3 (fr) | Composés et leurs utilisations | |
MA53085B1 (fr) | Thiophènecarboxamides substitués et analogues comme agents antibactériens | |
ZA202006612B (en) | Antibacterial compounds | |
WO2017218922A8 (fr) | Composés et méthodes pour le traitement d'infections bactériennes | |
EP4268897A3 (fr) | Composés de minocycline pour la défense biologique | |
EP4272831A3 (fr) | Diazabicyclooctanones comme inhibiteurs de sérine beta-lactamases | |
MX2022006109A (es) | Derivados 1-aminosulfonil-2-carboxipirrol como inhibidores de metalo-beta-lactamasa. | |
WO2014165126A3 (fr) | 3-styryl-céphalosporines dérivées | |
MX2019011908A (es) | Macrociclos de peptidos anti-bacterianos y uso de los mismos. | |
PH12019500331A1 (en) | Beta-lactamase inhibitors | |
WO2020014501A8 (fr) | Compositions et procédés pour le traitement d'infections bactériennes | |
MA39085A1 (fr) | Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne | |
MX2018011095A (es) | Compuestos de carbapenem. | |
ZA202001605B (en) | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections |